PT - JOURNAL ARTICLE AU - Tukiya Kanguya AU - Aybüke Koyuncu AU - Anjali Sharma AU - Thankian Kusanathan AU - Martha Mubanga AU - Benjamin H. Chi AU - Michael J. Vinikoor AU - Mwangelwa Mubiana-Mbewe TI - Identifying Barriers to Disclosure to Overcome Barriers to ART Initiation: An explanatory qualitative study on PMTCT in Zambia AID - 10.1101/2020.11.07.20227637 DP - 2020 Jan 01 TA - medRxiv PG - 2020.11.07.20227637 4099 - http://medrxiv.org/content/early/2020/11/10/2020.11.07.20227637.short 4100 - http://medrxiv.org/content/early/2020/11/10/2020.11.07.20227637.full AB - Background Though antiretroviral therapy (ART) is widely available, HIV positive pregnant women in Zambia are less likely to start and remain on therapy throughout pregnancy and after delivery. This study sought to understand readiness to start ART among HIV pregnant women from the perspectives of both women and men in order to suggest more holistic programs to support women to continue life-long ART after delivery.Methods We conducted a qualitative study with HIV positive pregnant women before and after ART initiation, and men with female partners, to understand readiness to start lifelong ART. We conducted a total of 28 in-depth interviews among women and 2 focus group discussions among male partners. Data was transcribed verbatim and analyzed in NVivo 12 using thematic analysis. Emerging themes from the data were organized using the social ecological framework.Results Men thought of their female partners as young and needing their supervision to initiate and stay on ART. Women agreed that disclosure and partner support were necessary preconditions to ART initiation and adherence and expressed fear of divorce as a prominent barrier to disclosure. Maternal love and desire to look after one’s children instilled a sense of responsibility among women which motivated them to overcome individual, interpersonal and health system level barriers to initiation and adherence. Women preferred adherence strategies that were discrete, the effectiveness of which, depended on women’s intrinsic motivation.Conclusion The results support current policies in Zambia to encourage male engagement in ART care. To appeal to male partners, messaging on ART should be centered on emphasizing the importance of male involvement to ensure women remain engaged in ART care. Programs aimed at supporting postpartum ART adherence should design messages that appeal to both men’s role in couples’ joint decision-making and women’s maternal love as motivators for adherence.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research has been supported by the President's Emergency Plan for AIDS Relief through the United States Centers for Disease Control and Prevention (CDC) under the terms of cooperative agreement number U01GH000530 (Funding recipient MMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the funding agencies.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval for the study was obtained from the University of Zambia Biomedical Research Ethics Committee (Lusaka, Zambia) and the University of North Carolina at Chapel Hill Institutional Review Board (Chapel Hill, NC, USA).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is accessible on request to: Chief Scientific Officer, P.O. Box 34681, Centre for Infectious Disease Research (CIDRZ), Lusaka, Zambia